Evotec and Dow AgroSciences Collaborate on Cellular Target Profiling
News Jul 09, 2013
To this end, Evotec will perform quantitative chemical proteomics services (Cellular Target Profiling) to de-convolute phenotypic screening results obtained by Dow.
Dr Mario Polywka, Chief Operating Officer of Evotec, commented: “We look forward to working with Dow AgroSciences on this project. This collaboration highlights the broad applicability of Evotec‘s industry leading chemical proteomics platform to determine cellular target affinities and mechanisms of action on a proteome wide level and in a native context.”
Dr William Kleschick, Discovery Global Leader of Dow AgroSciences, added: “Dow AgroSciences is pleased to announce this new partnership with Evotec, an innovative leader in advanced chemical proteomics. This collaboration enhances Discovery’s technology tool-box to accelerate our efforts to deliver novel solutions to our customers around the world.”
RELATED ARTICLES
Inside cells, where DNA is packed tightly in the nucleus and rigid proteins keep intricate transport systems on track, some molecules can simply self-organize, find one another in crowded spaces, and quickly coalesce into droplets. Now, new research shows how proteins that organize into liquid droplets inside cells make certain biological functions possible.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.
READ MORELike what you just read? You can find similar content on the communities below.
Drug Discovery Proteomics & MetabolomicsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
